文献速递脊柱外科

创口内妥布霉素粉末清除手术伤口污染:一项兔体内研究

Intrawound Tobramycin Powder Eradicates Surgical Wound Contamination: An In Vivo Rabbit Study.
PubMed 文献 · Spine (Phila Pa 1976) · 2017-01-01

研究在感染大肠埃希菌的兔脊柱植入模型中评估创口内妥布霉素粉末清除已知细菌污染的效果。20只兔行模拟部分椎板切除并植入钛丝后接种妥布霉素敏感大肠埃希菌,10只闭合前创口内放置妥布霉素粉末120 mg。术后第4天处死,组织培养妥布霉素组10只全部阴性、对照组10只全部阳性(P < 0.0001);对照组40份样本中39份有细菌生长,妥布霉素组40份样本中0份有生长(P < 0.0001)。结论认为在该兔脊柱感染模型中创口内妥布霉素清除了大肠埃希菌手术部位污染。

要点

  • 兔脊柱植入模型中,创口内妥布霉素粉末120 mg使组织培养全部转阴。
  • 无妥布霉素的对照兔全部持续存在大肠埃希菌污染。
  • 所有兔血培养阴性,无败血症或妥布霉素毒性证据。

核心结论

  • 在兔脊柱感染模型中,创口内妥布霉素清除了大肠埃希菌手术部位污染。
  • 所有未使用创口内妥布霉素的兔均存在持续大肠埃希菌污染。

研究设计与样本

  • 治疗性抗感染试验,在兔体内进行。
  • 20只健康新西兰白兔行模拟部分椎板切除并在L5-L6植入10 mm钛丝。
  • 所有手术部位接种100 μL妥布霉素敏感大肠埃希菌(EC ATCC 25922,1 × 10 CFU/mL)。
  • 闭合前10只兔创口内放置妥布霉素粉末120 mg,所有兔术后第4天处死。
  • 取出组织和钛丝样本行细菌学分析。

主要发现

  • 实验组与对照组体重分别为3.22 ± 0.12 kg与3.22 ± 0.14 kg(P = 1.0),性别分布和手术时长(13.1 ± 2.4分钟与11.6 ± 2.1分钟,P = 0.39)相似。
  • 组织样本培养:妥布霉素组10只全部阴性,对照组10只全部阳性(P < 0.0001)。
  • 对照组40份样本中39份有细菌生长,妥布霉素组40份样本中0份有生长(P < 0.0001)。
  • 所有兔血培养样本细菌生长阴性。
  • 无兔出现败血症或妥布霉素毒性证据。

关键数值与推荐

  • 创口内妥布霉素粉末剂量为120 mg。
  • 细菌接种量为100 μL大肠埃希菌(EC ATCC 25922,1 × 10 CFU/mL)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Therapeutic anti-infective trial in rabbits. OBJECTIVE: The purpose of the present study was to assess the efficacy of intrawound tobramycin powder in terms of eradicating a known bacterial contamination in an Escherichia coli-infected rabbit spinal implantation model. SUMMARY OF BACKGROUND DATA: Implant-associated surgical site infections (SSIs) remain a dreaded complication of spinal surgery. Currently, >30% of all spine SSIs are secondary to gram-negative bacteria. METHODS: Twenty healthy New Zealand white female rabbits underwent simulated partial laminectomies and implantation of a 10-mm titanium wire at L5-L6. All surgical sites were inoculated with 100 μL of tobramycin-sensitive E coli (EC ATCC 25922, 1 × 10 colony-forming units [CFU]/mL). Before closure, tobramycin powder (120 mg) was placed into the wound of 10 rabbits. All rabbits were sacrificed on postoperative day 4. Tissue and wire samples were explanted for bacteriologic analysis. A Fisher exact test was used to assess differences in categorical variables and an independent samples t test was used to assess mean group differences. RESULTS: The experimental and control rabbits were similar in weight (mean ± standard deviation, 3.22 ± 0.12 kg and 3.22 ± 0.14 kg, respectively, P = 1.0), sex distribution, and duration of surgery (13.1 ± 2.4 minutes and 11.6 ± 2.1 minutes, P = 0.39). Bacterial cultures of the tissue samples were negative for all 10 tobramycin-treated rabbits and positive for all 10 control rabbits (P < 0.0001). Bacterial growth occurred in 39 of 40 samples from control rabbits, but zero of the 40 samples from the tobramycin group (P < 0.0001). Blood culture samples from all rabbits were negative for bacterial growth. No rabbit had evidence of sepsis or tobramycin toxicity. CONCLUSION: In a rabbit spine-infection model, intrawound tobramycin eliminated E coli surgical site contamination. All rabbits without intrawound tobramycin had persistent E coli contamination. LEVEL OF EVIDENCE: N /A.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Laratta JL, Shillingford JN, Hardy N, et al. Intrawound Tobramycin Powder Eradicates Surgical Wound Contamination: An In Vivo Rabbit Study. Spine (Phila Pa 1976). 2017. PMID: 28399544. doi:10.1097/BRS.0000000000002187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。